Live Breaking News & Updates on Aurobindo Pharm

Stay updated with breaking news from Aurobindo pharm. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top Gainers And Losers In Stock Market On Budget Day 2024

Top Gainers And Losers In Stock Market On Budget Day 2024
indiatimes.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from indiatimes.com Daily Mail and Mail on Sunday newspapers.

Maruti Suzuki , Aurobindo Pharm , Nirmala Sitharaman , Central Public Sector Enterprises Cpses , Canara Bank , Container Corp , Finance Minister Nirmala Sitharaman , Finance Minister , Budget Day , India Cements , Central Public Sector Enterprises ,

Nifty, Sensex Trending Higher - Weekly Closing Report

After the Bhartiya Janata Party s decisive victories in Chattisgarh, Rajasthan, and Madhya Pradesh last Sunday, the market witnessed a robust rally, which briefly paused mid-week. However, as the week concluded, buying momentum resumed, propelling benchmark indices to fresh highs. This resurgence was attributed to positive global cues and the Reserve Bank of India s (RBI) optimistic revision of the FY23-24 GDP forecast to 7%, up from the earlier 6.5%, in its monetary policy announcement. ....

Saudi Arabia , Madhya Pradesh , Uttar Pradesh , Tamil Nadu , India General , Kingdom Of Saudi Arabia , Madivanan Balarishnan , Pradhanmantri Jan Arogya Yojana , Banswara Syntex , Sadhana Nitrochem , Naitwar Mori , Usha Martin , Aurobindo Pharm , Ayushman Bharat , Gross Development Value , Green Energy , International Conveyors , Canara Bank , Development Agreement , Syngene International , Tide Water Oil Company India Promoter , Genesys International Corporation , International Services , Brigade Group , Granules Pharmaceuticals Inc , Segment Of The Company ,

investments: Next big delta in pharma to come from biosimilars: Nithya Balasubramanian

“For Aurobindo Pharma, our official rating is market performance. We do not recommend it from a long-term perspective. It is only a tactical recommendation for the next couple of quarters for the reasons that you just read out. In the case of Gland Pharma, Bernstein sees operational leverage.” ....

Nithya Balasubramanian , Aurobindo Pharm , Aurobindo Pharma , Gland Pharma ,